Apoptosis Assays Market by Product - Global Forecast to 2023
According to the new market research report "Apoptosis
Assays Market by Product (Caspase, Annexin V, DNA Fragmentation,
Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence
microscopy), Application (Stem Cell, Discovery & Development, Clinical
Research) - Global Forecast to 2023", published by MarketsandMarkets™, The global apoptosis assays market is projected to
reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%.
This study involved the
extensive use of both primary and secondary sources. The research process
involved the study of various factors affecting the industry to identify the
segmentation types, industry trends, key players, competitive landscape, key
market dynamics, and key player strategies.
Secondary Research
Secondary research process involves the widespread use
of secondary sources, directories, databases (such as Bloomberg Business,
Factiva, and D&B Hoovers), white papers, annual reports, companies house
documents, investor presentations, and SEC filings of companies. Secondary
research was used to identify and collect information useful for the extensive,
technical, market-oriented, and commercial study of the apoptosis assays
market. It was also used to obtain important information about the key players
and market classification & segmentation according to industry trends to
the bottom-most level, and key developments related to market and technology
perspectives. A database of the key industry leaders was also prepared using
secondary research.
Browse and in-depth TOC on " Apoptosis Assays Market "
125 - Tables
37 - Figures
205 - Pages
View more detailed
TOC @
By application, the drug discovery & development
application segment is projected to have the largest market share during the
forecast period (2018-2023)”
Based on application, the apoptosis assays market is
segmented into drug discovery & development, clinical & diagnostic
applications, basic research, and stem cell research. In 2018, the drug
discovery & development application segment is expected to account for the
largest share of the global apoptosis assays market. The large share of this
segment can be attributed to the rising incidence and prevalence of chronic and
infectious diseases and increasing government support for developing new
treatments for various human diseases.
By
end user, the pharmaceutical and biotechnology companies segment is is
projected to have the largest market share during the forecast period
(2018-2023)”
On the basis of end user, the apoptosis assays
market is segmented into pharmaceutical and biotechnology companies, hospital
and diagnostic laboratories, and academic and research institutes. The
pharmaceutical and biotechnology companies segment is expected to account for
the largest share in 2018. The large share of this segment can be attributed to
the increasing number of R&D activities undertaken by these companies for
the development of biopharmaceutical products.
Avail Discount on Report – https://www.marketsandmarkets.com/discountreports.asp?id=9069428
Key
Players:
Merck KGaA (Germany), Thermo Fisher Scientific (US),
Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare
(US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US),
GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US),
PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK),
Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US) are among a few
major players in the industrial valve market.
Click
for Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=9069428
Comments
Post a Comment
If you have any issue, Let me know ?